Final report of the French multicenter phase II study of the nitrosourea fotemustine in 153 evaluable patients with disseminated malignant melanoma including patients with cerebral metastases (Q48868052)
scientific article
Language:
Current Data About Final report of the French multicenter phase II study of the nitrosourea fotemustine in 153 evaluable patients with disseminated malignant melanoma including patients with cerebral metastases
(P31) (Q13442814)
(P248)
(P698) 2224783
(P813) Friday, February 16, 2018
(P854) http://europepmc.org/abstract/MED/2224783

(P304) 1873-1878
(P248)
(P698) 2224783
(P813) Friday, February 16, 2018
(P854) http://europepmc.org/abstract/MED/2224783

(P407) (Q1860)

(P433) 9
(P248)
(P698) 2224783
(P813) Friday, February 16, 2018
(P854) http://europepmc.org/abstract/MED/2224783

(P478) 66
(P248)
(P698) 2224783
(P813) Friday, February 16, 2018
(P854) http://europepmc.org/abstract/MED/2224783

(P577) Thursday, November 1, 1990
(P248)
(P698) 2224783
(P813) Friday, February 16, 2018
(P854) http://europepmc.org/abstract/MED/2224783

(P921) (Q181600)

(P1433) (Q326041)
(P248)
(P698) 2224783
(P813) Friday, February 16, 2018
(P854) http://europepmc.org/abstract/MED/2224783

(P1476) "Final report of the French multicenter phase II study of the nitrosourea fotemustine in 153 evaluable patients with disseminated malignant melanoma including patients with cerebral metastases" (language: en)
(P248)
(P698) 2224783
(P813) Friday, February 16, 2018
(P854) http://europepmc.org/abstract/MED/2224783

(P2093) Jacquillat C
(P1545) 1
(P248)
(P698) 2224783
(P813) Friday, February 16, 2018
(P854) http://europepmc.org/abstract/MED/2224783

Khayat D
(P1545) 2
(P248)
(P698) 2224783
(P813) Friday, February 16, 2018
(P854) http://europepmc.org/abstract/MED/2224783

Banzet P
(P1545) 3
(P248)
(P698) 2224783
(P813) Friday, February 16, 2018
(P854) http://europepmc.org/abstract/MED/2224783

Weil M
(P1545) 4
(P248)
(P698) 2224783
(P813) Friday, February 16, 2018
(P854) http://europepmc.org/abstract/MED/2224783

Fumoleau P
(P1545) 5
(P248)
(P698) 2224783
(P813) Friday, February 16, 2018
(P854) http://europepmc.org/abstract/MED/2224783

Avril MF
(P1545) 6
(P248)
(P698) 2224783
(P813) Friday, February 16, 2018
(P854) http://europepmc.org/abstract/MED/2224783

Namer M
(P1545) 7
(P248)
(P698) 2224783
(P813) Friday, February 16, 2018
(P854) http://europepmc.org/abstract/MED/2224783

Bonneterre J
(P1545) 8
(P248)
(P698) 2224783
(P813) Friday, February 16, 2018
(P854) http://europepmc.org/abstract/MED/2224783

Kerbrat P
(P1545) 9
(P248)
(P698) 2224783
(P813) Friday, February 16, 2018
(P854) http://europepmc.org/abstract/MED/2224783

Bonerandi JJ
(P1545) 10
(P248)
(P698) 2224783
(P813) Friday, February 16, 2018
(P854) http://europepmc.org/abstract/MED/2224783

(P2860) (Q33465141)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1097-0142%2819901101%2966%3A9%3C1873%3A%3AAID-CNCR2820660904%3E3.0.CO%3B2-5
(P813) Sunday, January 21, 2018

other details